# C_2007045EN.01000701.xml

| 28.2.2007 | EN | Official Journal of the European Union | C 45/7 |
| --- | --- | --- | --- |

28.2.2007

EN

Official Journal of the European Union

C 45/7

---

Prior notification of a concentration

(Case COMP/M.4579 — Investor/Morgan Stanley/Mölnlycke)

(Text with EEA relevance)

(2007/C 45/06)

| 1. | On 20 February 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Investor AB (‘Investor’, Sweden) and Morgan Stanley Principal Investments Inc. (‘Morgan Stanley’, USA), belonging to the Morgan Stanley group, acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of the undertaking Mölnlycke Health Care UK Limited the holding company of Mölnlycke Health Care Group AB (‘Mölnlycke’, Sweden) by way of purchase of shares. |
| --- | --- |

1.

On 20 February 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings Investor AB (‘Investor’, Sweden) and Morgan Stanley Principal Investments Inc. (‘Morgan Stanley’, USA), belonging to the Morgan Stanley group, acquire within the meaning of Article 3(1)(b) of the Council Regulation joint control of the undertaking Mölnlycke Health Care UK Limited the holding company of Mölnlycke Health Care Group AB (‘Mölnlycke’, Sweden) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking Investor: investment company; |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking Investor: investment company;

| — | for undertaking Morgan Stanley: global financial service firm; |
| --- | --- |

—

for undertaking Morgan Stanley: global financial service firm;

| — | for undertaking Mölnlycke: provider of surgical, wound care and bandages products to the professional healthcare sector. |
| --- | --- |

—

for undertaking Mölnlycke: provider of surgical, wound care and bandages products to the professional healthcare sector.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4579 — Investor/Morgan Stanley/Mölnlycke, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (fax No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4579 — Investor/Morgan Stanley/Mölnlycke, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004 p. 1.

1

---